Cancer Research Cell Death Mechanisms and Cancer Therapy  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 8607, October 15, 2008. doi: 10.1158/0008-5472.CAN-08-0749
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albers, M. J.
Right arrow Articles by Kurhanewicz, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albers, M. J.
Right arrow Articles by Kurhanewicz, J.

Systems Biology and Emerging Technologies

Hyperpolarized 13C Lactate, Pyruvate, and Alanine: Noninvasive Biomarkers for Prostate Cancer Detection and Grading

Mark J. Albers1,2, Robert Bok2, Albert P. Chen2, Charles H. Cunningham3, Matt L. Zierhut1,2, Vickie Yi Zhang2, Susan J. Kohler4, James Tropp5, Ralph E. Hurd5, Yi-Fen Yen5, Sarah J. Nelson1,2, Daniel B. Vigneron1,2 and John Kurhanewicz1,2

1 Department of Bioengineering, University of California San Francisco and University of California Berkeley; 2 Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California; 3 Sunny Brook Health Sciences Centre, Toronto, Ontario, Canada; 4 Union College, Schenectady, New York; and 5 GE Healthcare, Menlo Park, California

Requests for reprints: John Kurhanewicz, University of California San Francisco, Byers Hall, Room 203E, 1700 4th Street, San Francisco, CA 94158-2330. Phone: 415-514-9711; Fax: 415-514-4714; E-mail: John.Kurhanewicz{at}radiology.ucsf.edu.

Key Words: Hyperpolarized 13C • Pyruvate • Alanine • Lactate • Prostate Cancer • Glycolysis

An extraordinary new technique using hyperpolarized 13C-labeled pyruvate and taking advantage of increased glycolysis in cancer has the potential to improve the way magnetic resonance imaging is used for detection and characterization of prostate cancer. The aim of this study was to quantify, for the first time, differences in hyperpolarized [1-13C] pyruvate and its metabolic products between the various histologic grades of prostate cancer using the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Fast spectroscopic imaging techniques were used to image lactate, alanine, and total hyperpolarized carbon (THC = lactate + pyruvate + alanine) from the entire abdomen of normal mice and TRAMP mice with low- and high-grade prostate tumors in 14 s. Within 1 week, the mice were dissected and the tumors were histologically analyzed. Hyperpolarized lactate SNR levels significantly increased (P < 0.05) with cancer development and progression (41 ± 11, 74 ± 17, and 154 ± 24 in normal prostates, low-grade primary tumors, and high-grade primary tumors, respectively) and had a correlation coefficient of 0.95 with the histologic grade. In addition, there was minimal overlap in the lactate levels between the three groups with only one of the seven normal prostates overlapping with the low-grade primary tumors. The amount of THC, a possible measure of substrate uptake, and hyperpolarized alanine also increased with tumor grade but showed more overlap between the groups. In summary, elevated hyperpolarized lactate and potentially THC and alanine are noninvasive biomarkers of prostate cancer presence and histologic grade that could be used in future three-dimensional 13C spectroscopic imaging studies of prostate cancer patients. [Cancer Res 2008;68(20):8607–15]




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Harris, G. Eliyahu, L. Frydman, and H. Degani
Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells
PNAS, October 27, 2009; 106(43): 18131 - 18136.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Matsumoto, H. Yasui, S. Batra, Y. Kinoshita, M. Bernardo, J. P. Munasinghe, H. Utsumi, R. Choudhuri, N. Devasahayam, S. Subramanian, et al.
Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI
PNAS, October 20, 2009; 106(42): 17898 - 17903.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Zaheer, S. Y. Cho, and M. G. Pomper
New Agents and Techniques for Imaging Prostate Cancer
J. Nucl. Med., September 1, 2009; 50(9): 1387 - 1390.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. C. Gore, T. E. Yankeelov, Todd. E. Peterson, and M. J. Avison
Molecular Imaging Without Radiopharmaceuticals?
J. Nucl. Med., June 1, 2009; 50(6): 999 - 1007.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.